- Display 15 Products per page
Published: August 19, 2015 | Price: $1,995.00 – $3,990.00
The IVD Market in Vietnam presents current analysis of the Vietnamese IVD industry. Vietnam has demonstrated fast economic growth in recent years. Increases in foreign investment, wages, trade, industrialization and tourism have led to economic growth higher than that of many other economies in Asia. As a result, IVD companies searching for emerging market areas to pursue growth that is no longer possible in developed nations have targeted Vietnam. The report takes an in-depth look at the market, providing data...Published: June 11, 2015 | Price: $1,995.00 – $3,995.00
IVD in China Market Outlook 2014-2024 With a population of more than 1 billion, China is the world’s largest country and therefore also its single largest potential market for goods and services. In the past ten years, China has led all major world economies in the average rate of growth in real GDP, total health expenditures, and government health expenditures. As an in vitro diagnostics (IVD) market, China trails only the populous, developed markets of the United States, western European countries,...Published: April 17, 2015 | Price: $499.00 – $1,000.00
The Market for Clinical Chemistry Routine clinical chemistry comprises 30 to 40 tests of substrates, metabolites, electrolytes, blood gases, enzymes and lipids that can be organized into panels for specialty patient investigation and routine patient screening. Common specialty panels include those for renal clearance, liver function, and metabolic status. Clinical chemistries are performed on analyzers with varying levels of automation depending on the test volume run at a particular test site. The market for routine clinical chemistries can be segmented...Published: January 31, 2015 | Price: $1,995.00 – $3,990.00
The Market for IVD in Latin America The Market for IVD in Latin America is an essential resource for IVD companies seeking market information for developing countries with growing economies. Kalorama Information, and VA Consultadora y Asociados of Argentina have published detailed nation by nation market analysis of the IVD markets in LATAM and thier segment markets. Each country in Latin America is different in terms of their healthcare system, insurance services, laws and industry participants. For this reason, this...Published: August 13, 2014 | Price: $1,995.00 – $3,990.00
The in vitro diagnostics (IVD) market attracts considerable interest. There are hundreds of participating companies, competing in multiple areas of testing. Each IVD segment could be said to function as an industry in and of itself. There are companies who specialize in one area and companies who participate across segments. There are myriad products, from routine blood tests to complicated molecular assays and new sequencing based technologies. It's often necessary for competitors to know about all of the segments of testing as different technologies can...Published: March 18, 2014 | Price: $1,995.00 – $3,990.00
The United States is the world’s largest in vitro diagnostics and nearly half of the global IVD market. While companies seek emerging markets for growth, most healthcare business is generated in the United States and its volume is still a strong advantage of this market. Most recently the U.S. IVD market weathered interrupted lab and healthcare sector investment in anticipation of the Affordable Care Act and several regulatory and austerity measures on the part of government payers that constricted payments...Published: December 16, 2013 | Price: $995.00 – $1,990.00
Full coverage of the IVD market in Mexico, including important IVD segments.Published: September 13, 2013 | Price: $1,500.00 – $3,000.00
Brazil is the fifth largest country in the world, after Russia, Canada, China and the United States. The size of the country as made it a focus for IVD companies. This report, The IVD Market in Brazil, provides market estimates and forecasts for the main categories of in vitro diagnostics, and forecasts those markets to 2017. Information was obtained by both primary and secondary sources. Annual reports, trade publications, as well as telephone and email surveys of IVD manufacturers operating...Published: August 5, 2013 | Price: $1,995.00 – $3,990.00
Australia represents a highly competitive IVD market with established international players, a highly developed export-intensive domestic industry, and highly consolidated clinical lab and testing industry. While other developed IVD markets in North America, Europe and Japan are not estimated to be achieving above 3% annual growth, the Australian IVD market has grown at an average of roughly 5% through the past five years. This rate of growth is projected to more or less continue with a stable funding environment through...Published: August 5, 2013 | Price: $2,500.00 – $5,000.00
This report, IVD in China represents Kalorama's complete analysis on the Chinese IVD market. The report provides an introduction to the healthcare system in China, the results of recent reform efforts, and issues and trends. Regional breakouts of the Chinese system are provided. The report describes the role that out-of-pocket expenditures and private concerns play in the delivery of healthcare in the nation. The modern Chinese healthcare market was borne of and continues to be guided by the progressive intentions...Published: February 23, 2013 | Price: $3,995.00 – $7,990.00
This report, Lab Automation Markets, 3rd Edition, (Systems, Key Companies, Forecasts and Trends), represents Kalorama Information's latest study of the market for systems that enable labs to store, identify and transport large quantities of specimens. The report analyzes the current and potential world markets for medical laboratory automation systems and equipment - both for clinical diagnostics and drug discovery research laboratories. Many clinical laboratories are facing a number of issues that are challenging their ability to remain competitive. These challenges...Published: December 6, 2012 | Price: $1,995.00 – $8,400.00
The World Market for Point of Care (POC) Diagnostics Visit our 'Point of Care Testing' curated page for complete industry coverage. Point-of-care (POC) tests are diagnostic tests that are performed at or near the site where the patient is located. They are performed in decentralized settings, outside of central hospital laboratories or centralized reference laboratories. Growth in POC testing is being fueled by many factors including the growing number of people with diabetes, the globalization of infectious diseases and the...Published: March 1, 2011 | Price: $1,500.00 – $2,500.00
This bundle provides customers with three of the most intensely researched Kalorama Information reports covering the diagnostic industry authored by Shara Rosen, R.T., M.B.A. in 2010 and 2011 These reports will be provided in one PDF, each with its own table of contents. The bundle allows customers to save almost $4,500 off the cost of the individual reports. THE WORLDWIDE MARKET FOR IN VITRO DIAGNOSTIC TESTS, 7th Edition This 900 page report contains coverage of all segments of In Vitro...Published: June 1, 2010 | Price: $4,995.00 – $9,990.00
NOTE: This report is based on 2008 Market Data The current population of India is 1.14 billion, and with a growth rate of 1.7%, India will surpass China to become the world’s largest country around 2030. For diagnostic manufacturers, this enormous market is just now being recognized as a high-growth area as the pace of economic growth in India accelerates and modern laboratory practices become established. This comprehensive report, produced in collaboration with IVD research firm McEvoy and Farmer on...Published: November 1, 2009 | Price: $3,995.00 – $7,990.00
As Kalorama Information's lead diagnostic analyst finds, the point of care concept is at a crossroads: the technologies needed to make rapid testing a reality have arrived. But is healthcare ready? Kalorama believes that the drive for wellness and the attention surrounding healthcare reform will focus attention on rapid diagnostics. However, according to Shara Rosen, RT, M.B.A., there are many challenges which must be overcome for point of care solutions to be fully utilized, and those companies willing to pivot...